1. Home
  2. NGVT vs BLTE Comparison

NGVT vs BLTE Comparison

Compare NGVT & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • BLTE
  • Stock Information
  • Founded
  • NGVT 1964
  • BLTE 2018
  • Country
  • NGVT United States
  • BLTE United States
  • Employees
  • NGVT N/A
  • BLTE N/A
  • Industry
  • NGVT Major Chemicals
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • BLTE Health Care
  • Exchange
  • NGVT Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • NGVT 2.1B
  • BLTE 2.1B
  • IPO Year
  • NGVT N/A
  • BLTE 2022
  • Fundamental
  • Price
  • NGVT $58.13
  • BLTE $69.48
  • Analyst Decision
  • NGVT Buy
  • BLTE Strong Buy
  • Analyst Count
  • NGVT 2
  • BLTE 4
  • Target Price
  • NGVT $58.00
  • BLTE $96.67
  • AVG Volume (30 Days)
  • NGVT 266.6K
  • BLTE 31.7K
  • Earning Date
  • NGVT 10-28-2025
  • BLTE 11-11-2025
  • Dividend Yield
  • NGVT N/A
  • BLTE N/A
  • EPS Growth
  • NGVT N/A
  • BLTE N/A
  • EPS
  • NGVT N/A
  • BLTE N/A
  • Revenue
  • NGVT $1,324,800,000.00
  • BLTE N/A
  • Revenue This Year
  • NGVT N/A
  • BLTE N/A
  • Revenue Next Year
  • NGVT $5.18
  • BLTE N/A
  • P/E Ratio
  • NGVT N/A
  • BLTE N/A
  • Revenue Growth
  • NGVT N/A
  • BLTE N/A
  • 52 Week Low
  • NGVT $28.49
  • BLTE $43.70
  • 52 Week High
  • NGVT $60.77
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 59.21
  • BLTE 59.70
  • Support Level
  • NGVT $56.99
  • BLTE $65.30
  • Resistance Level
  • NGVT $60.77
  • BLTE $69.69
  • Average True Range (ATR)
  • NGVT 1.48
  • BLTE 2.33
  • MACD
  • NGVT -0.39
  • BLTE 0.40
  • Stochastic Oscillator
  • NGVT 42.73
  • BLTE 94.56

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: